JAVIER
PUENTE VÁZQUEZ
Profesor asociado de Ciencias de la Salud
Centre Hospitalier de l’Université de Montréal
Montreal, CanadáPublicaciones en colaboración con investigadores/as de Centre Hospitalier de l’Université de Montréal (2)
2022
-
Niraparib in patients with metastatic castration-resistant prostate cancer and DNA repair gene defects (GALAHAD): a multicentre, open-label, phase 2 trial
The Lancet Oncology, Vol. 23, Núm. 3, pp. 362-373
2017
-
Randomized, double-blind, phase III trial of ipilimumab versus placebo in asymptomatic or minimally symptomatic patients with metastatic chemotherapy-naive castration-resistant prostate cancer
Journal of Clinical Oncology, Vol. 35, Núm. 1, pp. 40-47